Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Go back to Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
(NYSE: BHVN) Delayed: 13.41 +1.39 (11.56%)
Previous Close $12.02    52 Week High
Open $12.18    52 Week Low
Day High $13.46    P/E N/A 
Day Low $12.05    EPS
Volume 2,306,383